| Title | Tumour Virus Research |
| Abbreviation | Tumour Virus Res. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Infectious Diseases (Q1); Cancer Research (Q2); Virology (Q2) |
| h-index | 29 |
| Overall Rank/Ranking | 3615 |
| SCImago Journal Rank (SJR) | 1.097 |
| Impact Score | 3.69 |
| Publisher | Elsevier BV |
| Country | Netherlands |
| ISSN | 26666790 |
| Best Quartile | Q1 |
| Coverage History | 2021-2022 |
Tumour Virus Research is a journal covering the technologies/fields/categories related to Infectious Diseases (Q1); Cancer Research (Q2); Virology (Q2). It is published by Elsevier BV. The overall rank of Tumour Virus Research is 3615. According to SCImago Journal Rank (SJR), this journal is ranked 1.097. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 29. The best quartile for this journal is Q1.
The ISSN of Tumour Virus Research journal is 26666790. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Tumour Virus Research is cited by a total of 377 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Tumour Virus Research is 3.69, which is computed in 2023 as per its definition. Tumour Virus Research IF is decreased by a factor of 0.74 and approximate percentage change is -16.7% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Tumour Virus Research is 3.69. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.69 |
| 2021 | 4.43 |
| 2020 | 3.82 |
| 2019 | 3.01 |
| 2018 | 2.11 |
| 2017 | 2.68 |
| 2016 | 4.29 |
| 2015 | 0.00 |
Tumour Virus Research has an h-index of 29. It means 29 articles of this journal have more than 29 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Tumour Virus Research is 26666790. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Tumour Virus Research is 3615. According to SCImago Journal Rank (SJR), this journal is ranked 1.097. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.097 |
| 2021 | 1.146 |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3615 |
| 2021 | 3282 |
| 2020 | 34910 |
| 2019 | 32656 |
| 2018 | 34118 |
| 2017 | 34893 |
| 2016 | 34297 |
| 2015 | 33723 |
Tumour Virus Research is published by Elsevier BV. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2021-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Tumour Virus Research is Tumour Virus Res.. This abbreviation ('Tumour Virus Res.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Infectious Diseases (Q1); Cancer Research (Q2); Virology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Tumour Virus Research latest impact IF is 3.69. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 4.43 (2021) and 0.00 (2015), respectively, in the last 8 years. Moreover, its average IS is 3 in the previous 8 years.
The Tumour Virus Research has an SJR (SCImago Journal Rank) of 1.097, according to the latest data. It is computed in the year 2023. In the past 8 years, this journal has recorded a range of SJR, with the highest being 1.146 in 2021 and the lowest being in 2020. Furthermore, the average SJR of the Tumour Virus Research over the previous 8-year period stands at 3.
The latest h-index of the Tumour Virus Research is 29.
The Tumour Virus Research is published by the Elsevier BV, with its country of publication being the Netherlands.
The Tumour Virus Research is currently ranked 3615 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 8 years, this journal has experienced varying rankings, reaching its highest position of 3282 in 2021 and its lowest position of 34910 in 2020.
The standard ISO4 abbreviation for the Tumour Virus Research is Tumour Virus Res..
Tumour Virus Research is classified as a journal that the Elsevier BV publishes.
The Tumour Virus Research encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Tumour Virus Research is assigned the following International Standard Serial Numbers (ISSN): 26666790.
The best quartile for the Tumour Virus Research is Q1 (2022).
The Tumour Virus Research coverage history can be summarized as follows: 2021-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 16018 | Thieme Medical Publishers Inc. | 37 | 0.65 |
| Journal of Applied Business Research | journal | 23890 | 29 | 0.28 | |
| Mathematical Modelling and Analysis | journal | 11315 | Vilnius Gediminas Technical University | 27 | 1.75 |
| Marine Biology Research | journal | 13573 | Taylor and Francis Ltd. | 42 | 1.06 |
| Journal, Indian Academy of Clinical Medicine | journal | 24608 | Indian Academy of Clinical Medicine | 16 | 0.06 |
| Palaeontographica Abteilung B: Palaeophytologie | book series | 15138 | E. Schweizerbart'sche Verlagsbuchhandlung | 16 | 2.20 |
| Transboundary and Emerging Diseases | journal | 4279 | Wiley-Blackwell Publishing Ltd | 78 | 4.95 |
| PLoS ONE | journal | 5108 | Public Library of Science | 404 | 3.75 |
| Economics of Innovation and New Technology | journal | 6153 | Routledge | 62 | 3.55 |
| Health Economics, Policy and Law | journal | 8508 | Cambridge University Press | 41 | 1.66 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.69 |
| 2021 | 4.43 |
| 2020 | 3.82 |
| 2019 | 3.01 |
| 2018 | 2.11 |
| 2017 | 2.68 |
| 2016 | 4.29 |
| 2015 | 0.00 |
